https://allsci.com/news/licensing-and-partnerships/flu-vaccine-collaboration-osivax-and-gc-biopharma/ AllScien 2026-08-31T07:13:29.354821Z Osivax and GC Biopharma combine T-cell and antibody approaches in single-shot flu vaccine https://allsci.com/news/approvals/lisraya-dermatomyositis-fda-approval-approves-as/ AllScien 2026-08-31T07:11:25.162217Z FDA approves Lisraya as first targeted therapy for dermatomyositis https://allsci.com/news/approvals/fgfr2-intrahepatic-cholangiocarcinoma-approval/ AllScien 2026-08-31T07:09:05.024635Z HutchMed’s Atled wins China approval for FGFR2-driven bile duct cancer https://allsci.com/news/funding/samsung-biologics-polypeptide-acquisition-1/ AllScien 2026-08-31T07:03:09.860151Z Samsung Biologics raises USD 2.2b to fund PolyPeptide acquisition and capacity expansion https://allsci.com/news/approvals/comirnaty-xfg-fda-approval-approves-pfizer-and/ AllScien 2026-08-31T07:01:10.976342Z Pfizer and BioNTech's XFG-adapted Comirnaty given FDA clearance for fall 2026 rollout